Fueled Crestor generic market preoccupied by CJ and Ildong

In the market of ‘Crestor(rosuvastatin),’ a hyperlipidemia treatment which was jumped in by approximately 50 pharmaceutical companies last year, CJ HealthCare and Ildong Pharmaceutical have succeeded in getting a head start.

The original Crestor has not been able to avoid sales struggle which was caused by its patent expiration. However, the rosuvastatin market has consequently grew, and incre...